These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28268853)

  • 1. Optimal decision support rules improve personalize warfarin treatment outcomes.
    Chih-Lin Chi ; Ravvaz K; Weissert J; Tonellato PJ
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2594-2597. PubMed ID: 28268853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using simulation and optimization approach to improve outcome through warfarin precision treatment.
    Chi CL; He L; Ravvaz K; Weissert J; Tonellato PJ
    Pac Symp Biocomput; 2018; 23():412-423. PubMed ID: 29218901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing.
    Obeng AO; Kaszemacher T; Abul-Husn NS; Gottesman O; Vega A; Waite E; Myers K; Cho J; Bottinger EP; Ellis SB; Scott SA
    Clin Pharmacol Ther; 2016 Nov; 100(5):427-430. PubMed ID: 27393744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
    Schwartz JB; Kane L; Moore K; Wu AH
    J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.
    Higashi MK; Veenstra DL; Kondo LM; Wittkowsky AK; Srinouanprachanh SL; Farin FM; Rettie AE
    JAMA; 2002 Apr; 287(13):1690-8. PubMed ID: 11926893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of adequate use of warfarin for the elderly using decision tree-based approaches.
    Liu KE; Lo CL; Hu YH
    Methods Inf Med; 2014; 53(1):47-53. PubMed ID: 24136011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapy.
    You JH; Tsui KK; Wong RS; Cheng G
    Clin Pharmacol Ther; 2009 Nov; 86(5):540-7. PubMed ID: 19571807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential clinical and economic outcomes of pharmacogenetics-oriented management of warfarin therapy - a decision analysis.
    You JH; Chan FW; Wong RS; Cheng G
    Thromb Haemost; 2004 Sep; 92(3):590-7. PubMed ID: 15351856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].
    Liu Y; Zhong SL; Tan HH; Yang M; Fei HW; Yu XY; Lin SG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):929-35. PubMed ID: 22321278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.
    Arwood MJ; Deng J; Drozda K; Pugach O; Nutescu EA; Schmidt S; Duarte JD; Cavallari LH
    Clin Pharmacol Ther; 2017 May; 101(5):675-683. PubMed ID: 28032893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy.
    Shaw K; Amstutz U; Kim RB; Lesko LJ; Turgeon J; Michaud V; Hwang S; Ito S; Ross C; Carleton BC;
    Ther Drug Monit; 2015 Aug; 37(4):428-36. PubMed ID: 26186657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial neural network-based pharmacogenomic algorithm for warfarin dose optimization.
    Pavani A; Naushad SM; Kumar RM; Srinath M; Malempati AR; Kutala VK
    Pharmacogenomics; 2016; 17(2):121-31. PubMed ID: 26666467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
    Meckley LM; Wittkowsky AK; Rieder MJ; Rettie AE; Veenstra DL
    Thromb Haemost; 2008 Aug; 100(2):229-39. PubMed ID: 18690342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement.
    Quinn AL; Liko I; Lee JC
    Pharmacogenomics; 2017 Jul; 18(11):1051-1057. PubMed ID: 28685643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between CYP2C9 gene polymorphisms and upper gastrointestinal bleeding in patients who used warfarin.
    Ucar M; Alagozlu H; Sahin S; Ozdemir O
    Med Glas (Zenica); 2013 Feb; 10(1):50-4. PubMed ID: 23348161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
    Stergiopoulos K; Brown DL
    JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of sensitivity to warfarin based on VKORC1 and CYP2C9 polymorphisms in patients from different places in Colombia.
    Cifuentes RA; Murillo-Rojas J; Avella-Vargas E
    Biomedica; 2016 Mar; 36(1):91-100. PubMed ID: 27622442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of genetic and clinical factors on warfarin therapy in patients early after heart valve replacement surgery.
    Li B; Liu R; Wang C; Ren C; Zhang S; Zhang F; Zhang J; Liu S; Wei Y; Liu W; Song B; Wu X
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1685-1693. PubMed ID: 31444512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype and risk of major bleeding during warfarin treatment.
    Kawai VK; Cunningham A; Vear SI; Van Driest SL; Oginni A; Xu H; Jiang M; Li C; Denny JC; Shaffer C; Bowton E; Gage BF; Ray WA; Roden DM; Stein CM
    Pharmacogenomics; 2014 Dec; 15(16):1973-83. PubMed ID: 25521356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.
    Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J
    Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.